First human studies for Imagion cancer detection system
Imagion Biosystems have announced they will commence the first human trials of their MagSense cancer imaging system in Australia in the fourth quarter of 2020. The company is focused on identifying multiple trial sites for an initial enrolment of 15 to 20 patients subject to Human Research Ethics Committee approvals. Imagion’s MagSense is a new…